February 14, 2020 / 7:24 AM / 12 days ago

BRIEF-Ascelia Pharma Oct-Dec Operating Loss Widens To SEK 22.9 Mln

Feb 14 (Reuters) - Ascelia Pharma AB:

* 2019 YEAR-END FINANCIAL REPORT: SITES OPENED FOR RECRUITMENT TO THE PIVOTAL PHASE III STUDY SPARKLE

* OCT-DEC OPERATING RESULT OF SEK -22.9M (SEK -7.2M)

* OCT-DEC CASH FLOW FROM OPERATIONS OF SEK -16.8M (SEK -9.1M) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below